Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @IntClinTrials
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @IntClinTrials
-
Prikvačeni tweet
ICT November has arrived, tackling the complex world of site monitoring and risk-based approaches, innovative trial design, and dementia research – featuring articles from
@worldwidetrials and@ICONplc: http://bit.ly/2D1VQBO (Subscribe: http://bit.ly/36dcNq4 )pic.twitter.com/Snh3m4ghZv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Professor Clive Ballard at the University of Exeter Medical School and Dr Dawie Wessels
@PPDCRO examine how patient registries can improve the recruitment of dementia clinical trials: http://bit.ly/2SkUskL (Subscribe: http://bit.ly/36dcNq4 )pic.twitter.com/HENIZKfViZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ricky Lakhani
@pharmaseal speaks with ICT about the benefits and challenges of designing an effective trial management system: http://bit.ly/2uLNqNM (Subscribe: http://bit.ly/36dcNq4 )pic.twitter.com/xYZHUaE5bY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Tracy Goeken
@Accelovance examines the benefits of conducting clinical trials in Asia Pacific for its vast patient population: http://bit.ly/2rYgpwS (Subscribe: http://bit.ly/36dcNq4 )pic.twitter.com/4uhV0tnrfr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr Pavle Vukojevic, Dr Milan Marinkov, and Dr Jovana Vlajkovic-Josic
@Pharm_Olam present their formula for success in improving recruitment and streamlining rare disease trials: http://bit.ly/34tAokp (Subscribe: http://bit.ly/36dcNq4 )pic.twitter.com/bWjxGQApQN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
International Clinical Trials proslijedio/la je Tweet
Read
@IntClinTrials' recent article on "#RiskBasedMonitoring &#RWD: A Decentralised Ecosystem" for insights on the topic from ICON's Ian O’Shaughnessy http://ow.ly/ZKTg50xwOZQ pic.twitter.com/N1YoHaaBud
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
International Clinical Trials proslijedio/la je Tweet
Nurdan Citamak at Faubel Pharma Services writes on IoT applications and how supply chain can modernise... http://bit.ly/2LrCmuT (Subscribe here: http://bit.ly/2JtUpzw )pic.twitter.com/qmMtPmWqQl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Professor Clive Ballard at the University of Exeter Medical School and Dr Dawie Wessels at AES (
@PPDCRO) discuss new approaches to dementia prevention and the benefits of patient registries: http://bit.ly/381mdpR (Subscribe: http://bit.ly/36dcNq4 )pic.twitter.com/C0Ud0fgDaK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Shani McCoy at Berkshire Healthcare Foundation Trust assesses the factors that contribute to patient burden in dementia research: http://bit.ly/35QA5kE (Subscribe: http://bit.ly/36dcNq4 )pic.twitter.com/cKC89kOowv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
International Clinical Trials proslijedio/la je Tweet
What is the future of medicinal cannabis?
@MewburnEllisLLP's Callum McGuinn writes on the subject in the October issue of EBR. Read the article here: http://bit.ly/34py1Qi and subscribe here: http://bit.ly/2q5aDIZ pic.twitter.com/04lJG7kGcT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
François Torche
@CluePoints addresses the importance of more optimised monitoring approaches in clinical data science: http://bit.ly/2XQqbMZ (Subscribe: http://bit.ly/36dcNq4 )pic.twitter.com/eIHBrZQwVI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New barriers need to be addressed to accelerate cell therapy drug approvals, explains HemaCare’s Dominic Clarke and Brad N Taylor: http://bit.ly/2qDaVXA (Subscribe: http://bit.ly/2NZnIvl )pic.twitter.com/CS6GlzI5O1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
International Clinical Trials proslijedio/la je Tweet
Ruth Roberts from
@ApconiXLtd writes on the potential of artificial intelligence on the latest issue of EBR, read the article here: http://bit.ly/2NYlKv2 and subscribe here: http://bit.ly/2q5aDIZ pic.twitter.com/OqxajKHPoK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Pharma industry is more often now caught in the dichotomy between functional and full service provision, explains Daniel Chapple
@Quanticate: http://bit.ly/2NXSRPK (Subscribe: http://bit.ly/2NZnIvl )pic.twitter.com/rnIcakeUi2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For Susan Najjar at
@SciformixCorp, a Covance company, it’s important to ensure that business strategies are centred on the patient: http://bit.ly/2WFQs09 (Subscribe: http://bit.ly/2WIiPe7 )pic.twitter.com/WYmWjHek4S
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
International Clinical Trials proslijedio/la je Tweet
The relationships between universities and the pharmaceutical industry are changing, but are the changing for the better? Chiesi discuss… http://bit.ly/2Chf6e8 (Subscribe here: http://bit.ly/2JtUpzw )pic.twitter.com/pCx3gdopWz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
International Clinical Trials proslijedio/la je Tweet
Gary Skarja at
@Merck shares his knowledge on monoclonal antibodies in the EBR October article 'Next Generation Purification of Monoclonal Antibodies. You can read it here: http://bit.ly/2WTgbT3 and subscribe to EBR here: http://bit.ly/2PGHG0j pic.twitter.com/i7SJiGJ6NO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PIPA’s Emma Boulton and Dora Amene examine the legislation regulations involved in data compliance for pharmacovigilance: http://bit.ly/2Ng7sWq (Subscribe: http://bit.ly/2BRZq0O )pic.twitter.com/prCDD437p4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
International Clinical Trials proslijedio/la je Tweet
Patrick Liddy
@UtilityAR writes on 5 ways augmented reality will help the manufacturing process... http://bit.ly/31XN8ye (Subscribe here: http://bit.ly/2JtUpzw )pic.twitter.com/ATtIKfZHeK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PharSafer’s Graeme Ladds evaluated the responsibilities of sponsors and licence holders in pharmacovigilance outsourcing: http://bit.ly/2MRfq9x (Subscribe: http://bit.ly/2BRZq0O )pic.twitter.com/6IPiQm8Nqm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.